Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies
- PMID: 21040443
- PMCID: PMC4282796
- DOI: 10.1111/j.1538-7836.2010.04126.x
Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies
Abstract
Background: Knowledge of independent, baseline risk factors for catheter-related thrombosis (CRT) may help select adult cancer patients who are at high risk to receive thromboprophylaxis.
Objectives: We conducted a meta-analysis of individual patient-level data to identify these baseline risk factors.
Patients/methods: MEDLINE, EMBASE, CINAHL, CENTRAL, DARE and the Grey literature databases were searched in all languages from 1995 to 2008. Prospective studies and randomized controlled trials (RCTs) were eligible. Studies were included if original patient-level data were provided by the investigators and if CRT was objectively confirmed with valid imaging. Multivariate logistic regression analysis of 17 prespecified baseline characteristics was conducted. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated.
Results: A total sample of 5636 subjects from five RCTs and seven prospective studies was included in the analysis. Among these subjects, 425 CRT events were observed. In multivariate logistic regression, the use of implanted ports as compared with peripherally implanted central venous catheters (PICCs), decreased CRT risk (OR, 0.43; 95% CI, 0.23-0.80), whereas past history of deep vein thrombosis (DVT) (OR, 2.03; 95% CI, 1.05-3.92), subclavian venipuncture insertion technique (OR, 2.16; 95% CI, 1.07-4.34) and improper catheter tip location (OR, 1.92; 95% CI, 1.22-3.02), increased CRT risk.
Conclusions: CRT risk is increased with use of PICCs, previous history of DVT, subclavian venipuncture insertion technique and improper positioning of the catheter tip. These factors may be useful for risk stratifying patients to select those for thromboprophylaxis. Prospective studies are needed to validate these findings.
© 2011 International Society on Thrombosis and Haemostasis.
Figures
Similar articles
-
Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors.J Thromb Haemost. 2014 Jun;12(6):847-54. doi: 10.1111/jth.12549. J Thromb Haemost. 2014. PMID: 24612469
-
[Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer].Zhonghua Zhong Liu Za Zhi. 2024 Mar 23;46(3):256-262. doi: 10.3760/cma.j.cn112152-20231024-00218. Zhonghua Zhong Liu Za Zhi. 2024. PMID: 38494772 Chinese.
-
Conditional catheter-related thrombosis free probability and risk-adapted choices of catheter for lung cancer.Thorac Cancer. 2022 Jun;13(12):1814-1821. doi: 10.1111/1759-7714.14460. Epub 2022 May 13. Thorac Cancer. 2022. PMID: 35567315 Free PMC article.
-
Peripherally inserted central catheter-related thrombosis rate in modern vascular access era-when insertion technique matters: A systematic review and meta-analysis.J Vasc Access. 2020 Jan;21(1):45-54. doi: 10.1177/1129729819852203. Epub 2019 Jun 10. J Vasc Access. 2020. PMID: 31177939
-
Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care.Support Care Cancer. 2022 Oct;30(10):8577-8588. doi: 10.1007/s00520-022-07297-8. Epub 2022 Aug 6. Support Care Cancer. 2022. PMID: 35932317 Review.
Cited by
-
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).Clin Transl Oncol. 2024 Nov;26(11):2877-2901. doi: 10.1007/s12094-024-03605-2. Epub 2024 Aug 7. Clin Transl Oncol. 2024. PMID: 39110395 Free PMC article.
-
The Incidence, Risk Factors, and Patterns of Peripherally Inserted Central Catheter-Related Venous Thrombosis in Cancer Patients Followed Up by Ultrasound.Cancer Manag Res. 2021 Jun 1;13:4329-4340. doi: 10.2147/CMAR.S301458. eCollection 2021. Cancer Manag Res. 2021. PMID: 34103988 Free PMC article.
-
A Systematic Review of the Causes and Management of Ischaemic Stroke Caused by Nontissue Emboli.Stroke Res Treat. 2017;2017:7565702. doi: 10.1155/2017/7565702. Epub 2017 Oct 16. Stroke Res Treat. 2017. PMID: 29123937 Free PMC article. Review.
-
A systematic review of patient-related risk factors for catheter-related thrombosis.J Thromb Thrombolysis. 2015 Oct;40(3):363-73. doi: 10.1007/s11239-015-1175-9. J Thromb Thrombolysis. 2015. PMID: 25680892
-
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012 Feb;141(2 Suppl):e419S-e496S. doi: 10.1378/chest.11-2301. Chest. 2012. PMID: 22315268 Free PMC article.
References
-
- Rosovsky RP, Kuter DJ. Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management. Hematol Oncol Clin North Am. 2005;19:183–202. vii. S0889-8588(04)00116-9 [pii] 10.1016/j.hoc.2004.09.007. - PubMed
-
- McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348:1123–33. 10.1056/NEJMra011883 348/12/1123 [pii] - PubMed
-
- Povoski SP. Long-term venous access. In Cancer Management: A Multidisciplinary Approach. Medical, Surgical, and Radiation Oncology. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, editors. 11th edn CMP Medica (United Business Media); Lawrence: 2008. pp. 969–80.
-
- Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Anderson DR. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol. 2005;23:4063–9. JCO.2005.10.192 [pii] 10.1200/JCO.2005.10.192. - PubMed
-
- Karthaus M, Kretzschmar A, Kroning H, Biakhov M, Irwin D, Marschner N, Slabber C, Fountzilas G, Garin A, Abecasis NG, Baronius W, Steger GG, Sudhoff T, Giorgetti C, Reichardt P. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol. 2006;17:289–96. mdj059 [pii]10.1093/annonc/mdj059. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous